Skip to main content
. 2014 Aug 15;106(8):dju156. doi: 10.1093/jnci/dju156

Table 3.

Standardized mortality ratios in population-based cohort of 5-year survivors of ductal carcinoma in situ of the breast*

Cause ICD-10 Observed SMR (95% CI) AER
All causes† A00-Y89 941 1.04 (0.97 to 1.11) 5.7
Unknown cause 6
Circulatory system I00-99 195 0.77 (0.67 to 0.89) −10.2
 Myocardial infarction I21-22 43 0.83 (0.60 to 1.11) −1.6
 Other ischemic heart disease I20, 23-25 15 0.78 (0.44 to 1.29) −0.7
 Other heart disease I30-33, 39-52 47 0.69 (0.50 to 0.91) −3.8
 Cerebrovascular disease I60-69 52 0.77 (0.58 to 1.01) −2.7
 Other cardiovascular disease I00-15, 26-28, 34-52, 70-99 38 0.83 (0.59 to 1.14) −1.4

* Time at risk started 5 years after ductal carcinoma in situ diagnosis. Patients were censored at diagnosis of a second neoplasia treated with chemotherapy or radiotherapy above the diaphragm or date of emigration. AER = absolute excess risk per 10,000 patients per year; CI = confidence interval; ICD-10 = International Classification of Diseases, 10th Revision; SMR = standardized mortality ratio.

† Without taking censoring for second neoplasia into account.